Help Improve Outcomes

Prolonged inflammation doesn’t
help the Urology patient.  

Clarix® is the answer.

Clarix 1K is a cryopreserved ultra-thick human birth tissue allograft used as an adjunct for surgical applications. Clarix 1K supports a regenerative healing environment and the restoration of urinary and sexual function after Robot-Assisted Radical Prostatectomy (RARP) by managing inflammation, managing adhesion formation, and facilitating soft tissue healing. 1-2

Clarix is an ultra-thick allograft providing ease of use in robotic procedures.

Allograft placement over Neurovascular Bundles (NVBs) after prostate resection.

Introducing allograft into the surgical site using a single port robot.

Images courtesy of Mutahar Ahmed, MD, Hackensack Meridian Health, Hackensack, NJ

The Proof is in the Evidence

Improved clinical outcomes are supported by our published clinical evidence in Oncological Urology applications:

83% of patients achieved continency at 3-months when Clarix was used as an adjunct in RARP.1

75% of patients achieved potency at 6-months post-RARP with the use of Clarix.2

Optimal Patient Outcomes Matter.

At the time of surgery, give that one chance its best chance with Clarix.

Learn more about improved patient outcomes in RARP. Fill out the form below:  

  • By clicking the button below, I agree to receive marketing communications from BioTissue Holdings Inc. I am aware that I can unsubscribe at any time.
  • This field is for validation purposes and should be left unchanged.
References
Ahmed M, et al. J Robot Surg. 2020 Apr;14(2):283-289. doi: 10.1007/s11701-019-00972-9.
Stites, J., et al., Initial Experience with a Bioregenerative Matrix on Erectile Function Following Nerve-Sparing Robot-Assisted Laparoscopic Radical Prostatectomy, in World Congress of Endourology. 2018: Paris, France.
Images courtesy of: Mutahar Ahmed, MD, Hackensack Meridian Health, Hackensack, NJ.